Email Updates

You are here

Home

24 JULY 2020 VOLUME 22 ISSUE 29

Media Coverage

  • Vaginal Ring for HIV Prevention Receives Positive Opinion from European Regulator

    Today the European Medicines Agency (EMA) announced it has adopted a positive scientific opinion on the Dapivirine Vaginal Ring for use by cisgender women ages 18 and older in developing countries to reduce their risk of HIV infection. This milestone marks an important step toward expanding the number of biomedical HIV prevention options available to women in sub-Saharan Africa, who are among those most affected by the HIV epidemic.

    July 24, 2020
    Microbicides
    HIV.gov

  • Our Ending the Epidemic Plan Needs to Invest in PrEP—but Not Just the Cost of the Pill

    Ending the HIV Epidemic: A Plan for America (EHE) aims to end the HIV epidemic in the United States by 2030. Doing so requires a massive investment in HIV prevention efforts, largely focused on pre-exposure prophylaxis (PrEP), but this public health investment must support removing all the financial barriers to a patient being on PrEP, not just access to the medication.

    July 23, 2020
    PrEP
    The Body

  • Partnership Launches to Develop and Test HIV Antibody Combinations

    Scientists within the National Institutes of Health are collaborating with researchers at the nonprofit International AIDS Vaccine Initiative (IAVI) to develop and test combinations of HIV broadly neutralizing antibodies (bNAbs) that could be mass-produced at minimal cost as HIV treatment and prevention.

    July 23, 2020
    Antibody Related Research
    POZ

  • Community-Run PrEP Programme for Vietnamese Trans Women Sees Hundredfold Rise in Users in Three Years

    A PrEP programme in Vietnam set up for transgender women, and run largely by them, has seen the number of women enrolled in the programme increase from three in the second quarter of 2017 to 409 in the second quarter of 2020.

    July 22, 2020
    PrEP
    aidsmap

  • HIV Funding From Donor Governments Is Nearly the Same as a Decade Ago

    Last year, governments donated $7.8 billion in funds to battle HIV in low- and middle-income countries, which represents a $200 million reduction from the previous year and is nearly the same amount from a decade ago, according to a new report from Kaiser Family Foundation (KFF) and the Joint United Nations Programme on HIV/AIDS (UNAIDS).

    July 22, 2020
    General
    POZ

  • Q&A: Winnie Byanyima on Internal Reforms at UNAIDS

    Within the past six months, UNAIDS has appointed a staff counselor for mental health and well-being, created a standalone office for ethics, and enlisted the help of a feminist organization from India to advance the organization’s internal change agenda, according to the organization’s Executive Director Winnie Byanyima.

    July 22, 2020
    General
    Devex

  • Chatbots, Motorbikes: Southeast Asia HIV Centres Adapt to Coronavirus

    Five days after a coronavirus lockdown was imposed in Manila, charity LoveYourself hired 20 former motorcycle taxi riders, gave them a crash course on HIV and sent them off to deliver life-saving medication after signing confidentiality agreements.

    July 22, 2020
    General
    Thomson Reuters Foundation

  • How COVID-19 Threatens Efforts to Contain HIV/AIDS in South Africa

    When the COVID-19 pandemic began to spread rapidly across the globe, scientists expressed concern that people living with HIV would be particularly severely affected. This was because those with compromised immune systems are at increased risk of acquiring infections.

    July 20, 2020
    General
    The Conversation

  • Fears of HIV Spike in Jamaica As Pandemic Hits Prevention Efforts

    For about a month, John was woken by bad dreams, a side effect of missing his antiretroviral medication from late May, when he was unable to collect his prescription drugs due to COVID-19.

    July 20, 2020
    Treatment
    Reuters

  • Future HIV/AIDS Response: ‘Some Things We Will Need to Do Differently’

    Approaches to tackling persistent barriers preventing women and girls, and other key populations from exercising their rights and accessing critical services will need to change.

    July 20, 2020
    General
    Devex

  • 96 Weeks Results From Two African Studies Confirm Dolutegravir Non-Inferiority but Highlight Continued Weight Gain

    Last week, at the 23rd International AIDS Conference (AIDS 2020: Virtual), 96-week data from two major studies conducted in South Africa and Cameroon confirmed that dolutegravir is an important therapeutic option for people living with HIV in sub-Saharan Africa and other resource-limited settings. However, both studies highlighted the drug’s impact on weight gain.

    July 17, 2020
    Treatment
    aidsmap

  • Researchers Highlight Importance of Youth, Women in HIV Prevention Research

    Researchers discussed HIV prevention research during a press conference at the AIDS 2020 meeting, highlighting the importance of involving young people and women. The event included perspectives from various researchers on successful interventions and disruptions to treatment because of the COVID-19 pandemic.

    July 8, 2020
    Microbicides, PrEP
    Healio

Published Research

Announcements